<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>21</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>11</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Design of A Potential Multi-Epitope Vaccine against Toxoplasma gondii Based on Microneme Proteins Using A Comprehensive Immunoinformatics Approach</title>
    <FirstPage>445</FirstPage>
    <LastPage>456</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Nastaran</FirstName>
        <LastName>Paknejad</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, Faculty of Medicine, Shahed University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Dalir Ghaffari</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, Faculty of Medicine, Shahed University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Khadem Mohammadi</LastName>
        <affiliation locale="en_US">Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>10</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Toxoplasma gondii (T. gondii) is an intracellular apicomplexan parasite responsible for toxoplasmosis in humans and animals worldwide. Despite its high prevalence, no effective vaccine is currently available for human use. This study aimed to design and evaluate a multi-epitope vaccine candidate based on T. gondii microneme proteins (MIC2, MIC3, MIC4, MIC6, MIC8, and MIC13) using immunoinformatics approaches.
Methods: B-cell, cytotoxic T-lymphocyte (CTL), and helper T-lymphocyte (HTL) epitopes were predicted and screened based on their antigenicity, allergenicity, toxicity, and immunogenicity. Selected epitopes were linked using appropriate peptide linkers and fused with the 50S ribosomal protein L7/L12 adjuvant. The construct was further assessed for physicochemical properties, structural features, antigenicity, allergenicity, solubility, immune responses, and codon optimization.
Results: The final vaccine construct consisted of 624 amino acids with a predicted molecular weight of 64.97 kDa. The vaccine was predicted to be antigenic, stable, soluble, and non-allergenic. Structural analyses supported the quality of the refined model. Immune simulation indicated the induction of strong humoral and cellular immune responses, including enhanced antibody production and T-cell activation.
Conclusion: The designed multi-epitope vaccine demonstrated promising immunological and physicochemical characteristics.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/4484</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/4484/1526</pdf_url>
  </Article>
</Articles>
